Glucose and Insulin Secretory Response Patterns Following Diet and Tolazamide Therapy in Diabetes

Turtle, J. R.
September 1970
British Medical Journal;9/12/1970, Vol. 3 Issue 5723, p606
Academic Journal
No abstract available.


Related Articles

  • Pulsatile Insulin Release From Islets Isolated From Three Subjects With Type 2 Diabetes.  // Diabetes;Apr2002, Vol. 51 Issue 4, p988 

    Examines the dynamics of insulin release from islets isolated from three subjects with type 2 diabetes. Implication on the development of insulin resistance; Increment of insulin release; Relation between impaired secretory response to glucose and impaired metabolism.

  • Tolazamide.  // AHFS Consumer Medication Information;Oct2019, p1 

    Tolazamide is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Tolazamide is in a class of medications called...

  • Blood glucose monitoring: reducing the cost, increasing the benefit. Holt, Paula // British Journal of Community Nursing;Aug2007, Vol. 12 Issue 8, p337 

    The level of self blood glucose monitoring in patients who have diabetes has escalated over recent years following the results of two main research studies which identified a strong correlation between tight' blood glucose control and the reduction in diabetes related complications. This article...

  • Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes. Hollingdal, Malene; Juhl, Claus B.; Pincus, Steven M.; Sturis, Jeppe; Veldhuis, Johannes D.; Polonsky, Kenneth S.; Porksen, Niels; Schmitz, Ole; Hollingdal, M; Juhl, C B; Pincus, S M; Sturis, J; Veldhuis, J D; Polonsky, K S; Pørksen, N; Schmitz, O // Diabetes;Aug2000, Vol. 49 Issue 8, p1334 

    Insulin is released in high-frequency pulsatile bursts at intervals of 6-13 min. Intrapancreatic mechanisms are assumed to coordinate pulsatile insulin release, but small oscillations in plasma glucose concentrations may contribute further. To gain additional insight into beta-cell...

  • Diabetes: `Tight control' in a comprehensive treatment plan. Brown, Dale F.; Jackson, Thomas W. // Geriatrics;Jun94, Vol. 49 Issue 6, p24 

    Focuses on a comprehensive treatment strategy for the management of diabetes in older Americans. Effects of aging on glucose tolerance; Primary and secondary symptoms; Role of diet and exercise in diabetes management; Candidates for a tight glucose control; Oral hypoglycemics; Insulin therapy;...

  • Insulin secretion in type 1 diabetes. Steele, Chynna; Hagopian, William A.; Gitelman, Stephen; Masharani, Umesh; Cavaghan, Melissa; Rother, Kristina I.; Donaldson, David; Harlan, David M.; Bluestone, Jeffrey; Herold, Kevan C. // Diabetes;Feb2004, Vol. 53 Issue 2, p426 

    Type 1 diabetes, a chronic autoimmune disease, causes destruction of insulin-producing β-cells over a period of years. Although many markers of the autoimmune process have been described, none can convincingly predict the rate of disease progression. Moreover, there is relatively little...

  • Insulin Augmentation of Glucose-Stimulated Insulin Secretion Is Impaired in Insulin-Resistant Humans. Halperin, Florencia; Lopez, Ximena; Manning, Raquel; Kahn, C. Ronald; Kulkarni, Rohit N.; Goldfine, Allison B. // Diabetes;Feb2012, Vol. 61 Issue 2, p301 

    Type 2 diabetes (T2D) is characterized by insulin resistance and pancreatic β-cell dysfunction, the latter possibly caused by a defect in insulin signaling in b-cells. We hypothesized that insulin's effect to potentiate glucose-stimulated insulin secretion (GSIS) would be diminished in...

  • Variation in the calpain-10 gene affects blood glucose levels in the British population. Lynn, Stephen; White, Christopher; Frayling, Timothy M.; Hattersley, Andrew T.; Turnbull, Doug M.; Horikawa, Yukio; Cox, Nancy J.; Bell, Graeme I.; Walker, Mark; Evans, Julie C // Diabetes;Jan2002, Vol. 51 Issue 1, p247 

    Variation in the calpain-10 gene (CAPN10) has been shown to be associated with type 2 diabetes in Mexican-Americans and in at least three Northern European populations. Studies in nondiabetic Pima Indians showed that one of the at-risk DNA polymorphisms, single-nucleotide polymorphism (SNP)-43,...

  • Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults. Vauhkonen, I.; Niskanen, L.; Knip, M.; Ilonen, J.; Vanninen, E.; Kainulainen, S.; Uusitupa, M.; Laakso, M. // Diabetologia;Jan2000, Vol. 43 Issue 1, p69 

    Aims/hypothesis. This study was undertaken to investigate metabolic and genetic characteristics of latent autoimmune diabetes in adults (LADA).¶Methods. We evaluated insulin secretory capacity with oral and intravenous glucose tolerance tests (early insulin response) and hyperglycaemic clamp...

  • All about insulin.  // Diabetes Forecast;Aug94, Vol. 47 Issue 8, p57 

    Discusses various aspects of insulin. Source of insulin; Types of insulin; Details of insulin therapy for diabetics; Insulin delivery; Blood glucose control; Pointers on injecting insulin.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics